Effect of Dietary Energy Restriction on the Expression of Genes Encoding the Enzymes Involved in Steroidogenesis in Normal Breast Epithelium and Abdominal Adipose Tissue of Women with Excessive Adiposity Dietary energy restriction and steroidogenesis in normal breast epithelium and abdominal adipose tissue

Main Article Content

Danila Coradini https://orcid.org/0000-0003-3771-4341

Keywords

dietary energy restriction, steroidogenesis, gene expression, breast epithelium, abdominal adipose tissue

Abstract

Background: Weight gain and excessive adiposity are associated with an increased risk of breast cancer, especially in postmenopausal women with a high circulating level of testosterone. In this in silico study, the effect of the dietary energy restriction (DER) on the expression of a panel of genes coding for the main enzymes involved in androgens and estrogens production was investigated in breast epithelium and abdominal adipose tissue of healthy women with excessive adiposity and randomly allocated to DER for one menstrual cycle or asked to continue their usual diet.


Methods: Wilcoxon-Signed-Rank test was used to assess the difference between paired samples before and after DER in the breast epithelium or adipose tissue, and Spearman’s rank correlation was used to investigate the correlation between genes.


Results: In response to DER, the expression of HSD17B12, the gene encoding the enzyme that catalyzes the conversion of inactive estrone into bioactive estradiol, was significantly (P=0.0059) downregulated in breast epithelium and adipose tissue. Furthermore, the expression of HSD17B12 negatively correlated with that of the LRP1 gene (r= -0.91, P<0.0001), which codes for a multitasking protein recently proposed as a tumor suppressor in breast epithelium.


Conclusion: Present results showed that, in addition to the recognized systemic effects (reduction of the fatty mass and decrease of circulating biomarkers of breast cancer risk), DER could act locally by down-regulating the expression of some genes pivotally involved in the production of biologically active estrogens, thus contributing to prevent the estrogen-dependent initiation of breast cancer.

References

1. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193-201. doi: 10.1001/jama.296.2.193.
2. Engin A. Obesity-associated breast cancer: analysis of risk factors. Adv Exp Med Biol. 2017;960:571-606. doi: 10.1007/978-3-319-48382-5_25.
3. Vrieling A, Buck K, Kaaks R, Chang-Claude J. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat. 2010;123(3):641-9. doi: 10.1007/s10549-010-1116-4.
4. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2005;14(3): 656-61. doi: 10.1158/1055-9965.EPI-04-0001.
5. Teras LR, Goodman M, Patel AV, Diver WR, Flanders WD, Feigelson HS. Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women. Cancer Causes Control. 2011;22(4):573-9. doi: 10.1007/s10552-011-9730-y.
6. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6);629-42. doi: 10.1001/jama.295.6.629.
7. Dirx MJ, Zeegers MP, Dagnelie PC, van den Bogaard T, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer. 2003;106(5):766-70. doi: 10.1002/ijc.11277.
8. Howell A, Chapman M, Harvie M. Energy restriction for breast cancer prevention. Recent Results Cancer Res. 2008;181:97-111. doi: 10.1007/978-3-540-69297-3_11.
9. Harvie M, Howell A. Energy balance adiposity and breast cancer—energy restriction strategies for breast cancer prevention. Obes Rev. 2006;7(1):33-47. doi: 10.1111/j.1467-789X.2006.00207.x.
10. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem. 2008;114(1):63-70. doi: 10.1080/13813450801954451.
11. Ong KR, Sims AH, Harvie M, Chapman M, Dunn WB, Broadhurst D, Goodacre R, Wilson M, Thomas N, Clarke RB, Howell A. Biomarkers of dietary energy restriction in women at increased risk of breast cancer. Cancer Prev Res. 2009;2(8):720-31. doi: 10.1158/1940-6207.CAPR-09-0008.
12. Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54(4):343-9. doi: 10.1016/s0895-4356(00)00314-0.
13. Laplante Y, Rancourt C, Poirier D. Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors. Mol Cell Endocrinol. 2009;301(1):146-53. doi: 10.1016/j.mce.2008.08.026.
14. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, et al. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer. 2005;12(4):701-20. doi: 10.1677/erc.1.00834.
15. Aka JA, Mazumdar M, Lin SX. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. Mol Cell Endocrinol. 2009;301(1-2):183-90. doi: 10.1016/j.mce.2008.10.042.
16. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 α-hydroxysteroid dehydrogenase activity. J Biol Chem. 1993;268(17):12964-9. doi: Not Available
17. Emonard H, Théret L, Bennasroune AH, Dedieu S. Regulation of LRP-1 expression: make the point. Pathol Biol. 2014;62(2):84-90. doi: 10.1016/j.patbio.2014.02.002.
18. Okada SS, Grobmyer SR, Barnathan ES. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler Thromb Vasc Biol. 1996;16(10):1269-76. doi: 10.1161/01.atv.16.10.1269.
19. van der Geer P. Phosphorylation of LRP1: regulation of transport and signal transduction. Trends Cardiovasc Med. 2002;12(4):160-5. doi: 10.1016/s1050-1738(02)00154-8.
20. Kinoshita A, Shah T, Tangredi MM, Strickland DK, Hyman BT. The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J Biol Chem. 2003;278(42):41182-8. doi: 10.1074/jbc.M306403200.
21. Lillis AP, Mikhailenko I, Strickland DK. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost. 2005;3(8):1884-93. doi: 10.1111/j.1538-7836.2005.01371.x.
22. Suzuki T, Darnel A, Akahira JI, Ariga N, Ogawa S, Kaneko C, et al. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions. J Clin Endocrinol Metab. 2001;86(5):2250-7. doi: 10.1210/jcem.86.5.7444.

Article Statistics :Views : 92 | Downloads : 38 : 10